13 drug(s) with this reaction
14,401 total reports
Malaise has been reported as an adverse reaction across 13 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,401 adverse event reports mention malaise in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with malaise, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have malaise listed in their FDA adverse event reports, sorted by report count:
In addition to malaise, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
13 drug(s) manufactured by Amgen Inc have malaise listed in their FDA adverse event reports: APREMILAST, DENOSUMAB, CINACALCET HYDROCHLORIDE, ERENUMAB-AOOE, PEGFILGRASTIM, and others.
There are a combined 14,401 reports of malaise across 13 Amgen Inc drug(s) in the FDA adverse event database.